In 1993 and 1995, we detailed body mass growth rates, plumage development, and related behaviors of Snowy Owl (Bubo scandiacus) nestlings from Barrow, Alaska. We recorded data from 71 of 80 nestlings from 14 of 20 nests in 1993 and 154 of 161 nestlings from 33 of 54 nests in 1995. Only nestlings for which we had data from hatching to at least 25 d of age were included in the growth model. Nestlings hatched between 1–3 d after “pipping” (creating a hole in) the eggshell. The semi-altricial young were covered in white protoptile (first) down plumage at hatching and weighed about 44–45 g. For about the first 7 d, their eyes were closed and movement was limited; the nestlings were dependent on the female for thermoregulation, food, and protection. Growth was rapid and by 8–9 d, the dark gray mesoptile (second) down had begun replacing protoptile down. By about 9–11 d, eyes were open, and by about 14 d, the owls were dark gray in color, and primary flight feather quills emerged. Mass gains were greatest the week prior to pre-fledging nest departure. The owls gained about 56 g every d, between 16–22 d. Around 21 d, the primary flight feathers erupted from their quills, and at approximately 25 d, tail (rectrices) feather quills erupted. After pre-fledging nest departure at approximately 21 d, the young owls roamed the tundra on foot and were fed and protected by both parents. We did not observe voluntary brood reduction; however, some young died in nests. Mass growth slowed substantially by about 34 d, while plumage development, particularly flight feather growth, increased rapidly. Young within and between nests, and years, grew at similar rates. Around 36–43 d, the young began their first attempts at flying, by hopping and pumping their wings. Also at this age, differences in plumage between presumed males and females were noticeable. Between 44 and 55 d, the young fledged, coinciding with the time when primary flight feather P8 reached 16.5 cm, and tail feather T1 reached 11.0 cm.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 50 • No. 2